These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2627973)

  • 41. Ovarian carcinoma: adjuvant treatment with P-32.
    Reddy S; Sutton GP; Stehman FB; Hornback NB; Ehrlich CE
    Radiology; 1987 Oct; 165(1):275-8. PubMed ID: 3628782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiotherapy in early ovarian cancer.
    Thomas GM
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S73-9. PubMed ID: 7835813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the prognostic factors in patients with stage-I and -II ovarian cancer treated by an operation + irradiation variant].
    Tarlowska L; Czesnin K; Psikuta M; Romejko M
    Vopr Onkol; 1986; 32(3):36-44. PubMed ID: 3962255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in ovarian cancer.
    Rakar S; Kovacic J; Cavic M; Lukanovic A; Mozina A
    Eur J Gynaecol Oncol; 1990; 11(3):171-3. PubMed ID: 2170137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Seidal T
    Int J Gynecol Cancer; 2001; 11(2):119-29. PubMed ID: 11328410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas.
    Kumar A; Le N; Gilks CB; Santos JL; Wong F; Swenerton K; Hoskins PJ; McAlpine JN; Tinker AV
    Int J Gynecol Cancer; 2017 Nov; 27(9):1819-1825. PubMed ID: 28930809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Radiotherapy in primary radically operated ovarian cancer].
    Frischbier HJ; Bahnsen J
    Onkologie; 1985 Oct; 8(5):310-5. PubMed ID: 2999669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperfractionation of whole-abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy.
    Morgan L; Chafe W; Mendenhall W; Marcus R
    Gynecol Oncol; 1988 Sep; 31(1):122-36. PubMed ID: 3410343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stage III ovarian carcinoma: an analysis of treatment results and complications following hyperfractionated abdominopelvic irradiation for salvage.
    Fein DA; Morgan LS; Marcus RB; Mendenhall WM; Sombeck MD; Freeman DE; Million RR
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):169-76. PubMed ID: 8175425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy and radiation therapy in the treatment of ovarian carcinoma of common epithelial origin.
    Wharton JT; Edwards CL; Stringer CA; Delclos L
    Clin Obstet Gynecol; 1985 Dec; 28(4):806-15. PubMed ID: 4075632
    [No Abstract]   [Full Text] [Related]  

  • 53. External beam radiotherapy in the management of ovarian carcinoma.
    Reinfuss M; Kojs Z; Skołyszewski J
    Radiother Oncol; 1993 Jan; 26(1):26-32. PubMed ID: 8438083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of early stages of ovarian carcinoma. Evaluation of experience at the Institute of Radiation Oncology over a 10-year period (1983-1993)].
    Kulhavý M; Petera J; Kmonícková E; Stáhalová V; Stankusová H; Zámecník J; Lapes M
    Ceska Gynekol; 1997 Aug; 62(4):213-6. PubMed ID: 9600154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole abdominal radiotherapy following cytoreductive surgery and chemotherapy in ovarian carcinoma.
    Kersh CR; Randall ME; Constable WC; Hahn SS; Taylor PT; Krebs HB; Goplerud DR
    Gynecol Oncol; 1988 Sep; 31(1):113-21. PubMed ID: 3410342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Postoperative radiotherapy of epithelial ovarian cancers].
    Kucera H; Sevelda P; Genger H; Weghaupt K
    Geburtshilfe Frauenheilkd; 1985 Dec; 45(12):848-52. PubMed ID: 4085759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations.
    Dembo AJ; Bush RS; Beale FA; Bean HA; Pringle JF; Sturgeon JF
    Cancer Treat Rep; 1979 Feb; 63(2):249-54. PubMed ID: 109198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelial ovarian cancer: the role of radiotherapy.
    Dembo AJ
    Int J Radiat Oncol Biol Phys; 1992; 22(5):835-45. PubMed ID: 1555974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis.
    Debby A; Levy T; Hayat H; Brenner Y; Glezerman M; Menczer J
    Int J Gynecol Cancer; 2004; 14(5):794-8. PubMed ID: 15361186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The evaluation of postoperative irradiation in patients with early-stage ovarian cancer.
    Leers WH; Kock HC
    Gynecol Oncol; 1987 Sep; 28(1):41-9. PubMed ID: 3653769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.